Original Research Articles

The Original Research Articles section publishes original, high-quality scientific investigations that advance knowledge in medicine, biomedical sciences, clinical laboratory sciences, molecular biology, and related disciplines.

 Submissions must present novel findings derived from appropriately designed experimental, observational, clinical, translational, or laboratory-based studies. Manuscripts should clearly describe the research objectives, methodology, results, and conclusions, with sufficient detail to support scientific evaluation and reproducibility.

 All manuscripts undergo an initial editorial assessment for relevance, scientific quality, originality, and compliance with ethical standards. Manuscripts that pass this assessment are subjected to independent peer review before an editorial decision is made.

 Authors must disclose relevant conflicts of interest, funding sources, and ethical approvals where applicable. Research involving human participants or animals must comply with applicable ethical and regulatory requirements.

Review Articles

The Review Articles section of NORD Medicine and Biomedical Research publishes comprehensive, critical, and scholarly reviews of current knowledge in medicine, biomedical sciences, clinical sciences, molecular biology, and related disciplines.

Review articles should provide a balanced synthesis of relevant scientific literature, critically evaluate existing evidence, identify knowledge gaps, and discuss emerging developments and future research directions.

Submissions should demonstrate scientific rigor, originality of interpretation, and relevance to researchers, healthcare professionals, and the broader scientific community. Authors should clearly describe the scope and objectives of the review and explain their approach to identifying and selecting the literature.

All submitted review articles undergo initial editorial screening followed by independent peer review when deemed suitable. Authors must appropriately acknowledge all sources and disclose funding and potential conflicts of interest.

Systematic Reviews and Meta-Analyses

The Systematic Reviews and Meta-Analyses section of NORD Medicine and Biomedical Research publishes rigorous, comprehensive, and methodologically sound systematic reviews and meta-analyses addressing important questions in medicine, biomedical sciences, clinical research, public health, and related disciplines.

Submissions must employ transparent, reproducible, and scientifically appropriate methods for identifying, selecting, critically appraising, and synthesizing relevant research evidence. Systematic reviews should address clearly defined research questions and describe their eligibility criteria, information sources, search strategies, study selection procedures, data extraction methods, and approaches to assessing risk of bias.

Where appropriate, meta-analyses should employ suitable statistical methods to combine study findings, evaluate heterogeneity, and assess the robustness of pooled estimates. Authors must clearly justify their analytical approaches and acknowledge relevant methodological limitations.

Authors are expected to follow applicable reporting guidelines, including the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) statement. A completed PRISMA checklist and study selection flow diagram should accompany submissions where applicable. Prospective protocol registration, such as registration in PROSPERO or another appropriate registry, is strongly encouraged, and registration details should be reported when available.

All submissions undergo initial editorial assessment and independent peer review when deemed suitable. Authors must disclose funding sources, potential conflicts of interest, and any deviations from registered or published review protocols.

Case Reports

The Case Reports section of NORD Medicine and Biomedical Research publishes clinically significant and educational case reports that contribute to medical knowledge, improve clinical practice, or provide new insights into disease diagnosis, management, and patient outcomes.

Submissions may describe rare or unusual diseases, atypical clinical presentations, diagnostic challenges, unexpected treatment responses, novel clinical observations, adverse drug reactions, or other cases with important implications for clinical practice and biomedical research.

Case reports should clearly present the clinical background, patient information, relevant medical history, clinical findings, diagnostic assessments, therapeutic interventions, outcomes, and follow-up where applicable. Authors should provide a critical discussion of the case in the context of existing scientific literature and identify its educational or clinical significance.

Authors are expected to follow the CARE (CAse REport) reporting guidelines and submit a completed CARE checklist where applicable.

Patient confidentiality and privacy must be protected. Authors must remove unnecessary identifying information and obtain appropriate informed consent for publication from the patient or an authorized representative when required. Identifiable photographs, clinical images, and other potentially identifying information must not be published without appropriate consent. Authors must comply with applicable institutional ethical requirements and relevant laws and regulations. The journal may request documentation confirming that consent has been obtained.

All submissions undergo initial editorial assessment for clinical relevance, originality, ethical compliance, and educational value. Manuscripts deemed suitable are subjected to independent peer review before an editorial decision is made.

Authors must disclose funding sources, potential conflicts of interest, and relevant ethical approvals or exemptions, where applicable.

Short Communications

The Short Communications section of NORD Medicine and Biomedical Research publishes concise, original, and scientifically significant research findings in medicine, biomedical sciences, clinical laboratory sciences, molecular biology, public health, and related disciplines.

Short Communications are intended for focused investigations that present novel observations, important experimental findings, methodological advances, or preliminary results of scientific interest that can be adequately communicated in a shorter manuscript format.

Submissions must demonstrate scientific originality, methodological rigor, and relevance to the journal's scope. Although shorter than full-length original research articles, manuscripts must provide sufficient methodological detail, appropriate statistical analysis where applicable, and adequate supporting evidence to permit critical scientific evaluation and reproducibility.

Manuscripts should be organized into an abstract, introduction, materials and methods, results, discussion, conclusions, and references, where appropriate. Results and discussion may be combined when justified by the nature of the study.

The recommended maximum manuscript length is 2,500 words, excluding the abstract, references, tables, and figure legends. Authors should generally limit submissions to three figures or tables in total and approximately 25 references. Supplementary materials may be submitted when necessary to support the findings.

All submissions undergo initial editorial screening followed by independent peer review when deemed suitable. Authors must comply with applicable research ethics requirements, disclose funding sources and potential conflicts of interest, and obtain appropriate ethical approvals for studies involving human participants or animals.

Preliminary findings must be clearly identified as such, and conclusions must not exceed the evidence presented.

Methodological Articles

The Methodological Articles section of NORD Medicine and Biomedical Research publishes original research describing the development, optimization, validation, application, or critical evaluation of scientific methodologies relevant to medicine, biomedical sciences, clinical laboratory sciences, molecular biology, biotechnology, and related disciplines.

Submissions may address innovative laboratory techniques, diagnostic assays, molecular and cellular methods, analytical procedures, bioinformatics tools, computational approaches, clinical research methodologies, experimental protocols, and technological advances that improve research quality, diagnostic accuracy, reproducibility, efficiency, or scientific understanding.

Manuscripts should clearly describe the scientific rationale, methodological principles, experimental design, materials, equipment, procedures, analytical approaches, and relevant quality control measures. Authors must provide sufficient technical detail to enable independent evaluation and reproducibility of the described methodology.

Where applicable, studies should include appropriate method validation data, such as analytical sensitivity, specificity, accuracy, precision, reproducibility, linearity, detection limits, measurement uncertainty, or other relevant performance characteristics. Comparisons with established reference methods or existing technologies are encouraged when appropriate.

Methodological Articles may also describe substantial improvements to existing techniques, provided that the modifications demonstrate meaningful scientific or practical advantages supported by appropriate experimental evidence.

Authors should discuss the strengths, limitations, applicability, and potential implications of the proposed methodology for biomedical research, laboratory medicine, clinical diagnostics, or healthcare delivery.

Manuscripts should generally include an abstract, introduction, materials and methods, results, discussion, conclusions, and references. Detailed protocols, supplementary datasets, software code, validation reports, or other supporting materials should be provided when necessary to facilitate reproducibility.

The recommended maximum manuscript length is 5,000 words, excluding the abstract, references, tables, figure legends, and supplementary materials. Authors should generally limit submissions to six figures or tables in total and approximately 50 references. Exceptions may be considered when scientifically justified.

All submissions undergo initial editorial screening for originality, methodological rigor, scientific relevance, and compliance with ethical standards. Manuscripts deemed suitable are subjected to independent peer review before an editorial decision is made.

Authors must disclose funding sources, potential conflicts of interest, and relevant ethical approvals where applicable. Studies involving human participants, human biological materials, or animals must comply with applicable institutional, national, and international ethical requirements.

Perspectives and Commentaries

The Perspectives and Commentaries section of NORD Medicine and Biomedical Research publishes scholarly perspectives, critical analyses, and evidence-informed commentaries addressing important developments, emerging challenges, controversies, and future directions in medicine, biomedical sciences, clinical laboratory sciences, public health, and related disciplines.

This section provides a platform for researchers, clinicians, educators, policymakers, and other qualified professionals to present informed viewpoints on scientific discoveries, healthcare innovations, research methodologies, clinical practices, biomedical technologies, health policies, and issues of broad scientific or societal significance.

Perspectives

Perspective articles present forward-looking interpretations, expert insights, or critical analyses of emerging scientific developments. Submissions should offer original intellectual contributions, identify important knowledge gaps, propose innovative approaches, or discuss potential directions for future research and clinical practice.

Commentaries

Commentaries provide concise, scholarly discussions of recently published research, emerging scientific evidence, clinical developments, ethical issues, healthcare policies, or topics of current relevance to the biomedical community. Authors should critically evaluate the subject matter, highlight its implications, and support their arguments with appropriate scientific evidence.

Manuscript Requirements

All submissions must be clearly written, scientifically informed, logically structured, and supported by relevant scholarly references. Authors should distinguish established scientific evidence from personal interpretations, hypotheses, and opinions.

Manuscripts should generally include an abstract, introduction, main discussion, conclusions, and references. The organization may be adapted to the nature of the article.

The recommended maximum manuscript length is 3,000 words, excluding the abstract and references. Authors should generally limit submissions to approximately 30 references and two figures or tables, unless additional material is scientifically justified.

Perspectives and Commentaries must not present unsupported scientific claims, misleading interpretations, or promotional content. Statements concerning clinical interventions, diagnostic technologies, or public health recommendations must be supported by appropriate evidence.

Editorial Assessment and Peer Review

All submissions undergo initial editorial screening to assess scientific relevance, originality of interpretation, clarity, scholarly merit, and compliance with journal policies. Manuscripts deemed suitable undergo independent peer review before an editorial decision is made.

Authors must disclose relevant funding sources, institutional affiliations, and potential conflicts of interest. Articles discussing commercial products, technologies, or healthcare interventions must maintain scientific objectivity and transparency.

The journal welcomes constructive scientific debate and diverse evidence-based perspectives while maintaining high standards of academic integrity, professionalism, and ethical publishing.